Esperion Therapeutics’ (ESPR) “Market Outperform” Rating Reiterated at JMP Securities
JMP Securities reissued their market outperform rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. They ...
H.C. Wainwright Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
H.C. Wainwright Keeps Their Buy Rating on Lexicon Pharmaceuticals (LXRX)
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), ...
Exelixis’ (EXEL) “Equal Weight” Rating Reiterated at Stephens
Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Stephens in a research note issued to investors on Wednesday,Benzinga reports.